Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems

Sponsor
Medical University of South Carolina (Other)
Overall Status
Completed
CT.gov ID
NCT00366665
Collaborator
(none)
30
2

Study Details

Study Description

Brief Summary

To compare the efficiency of the Infiniti vision system and the Series 20000 Legacy System phacoemulsification units during routine cataract extraction.

Condition or Disease Intervention/Treatment Phase
  • Device: Legacy 20000
  • Device: Infinit system
N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Comparison of the Infiniti Vision and the Series 20000 Legacy Systems
Study Start Date :
Mar 1, 2005
Study Completion Date :
May 1, 2005

Outcome Measures

Primary Outcome Measures

  1. Ultrasound time []

  2. Amount of fluid used []

  3. Post operative visual acuity. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Cataract

  • Eligible for cataract extraction with primary implantation of a posterior chamber IOL

  • 2 to 3+ cataract density

Exclusion Criteria:
  • Preoperative ocular pathology that can affect visual acuity

  • Corneal irregularities such as keratoconus, corneal dystrophy, corneal opacities.

  • Previous intraocular or corneal surgery.

  • Other ocular surgery at the time of the cataract extraction.

  • Surgical Exclusion Criteria:

  • Significant intraoperative intraocular bleeding

  • Detached Descemet's membrane

  • Implantation of the intraocular lens in the anterior chamber or sulcus

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Medical University of South Carolina

Investigators

  • Principal Investigator: Kerry D. Solomon, MD, Medical University of South Carolina

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00366665
Other Study ID Numbers:
  • MRC-05-002
First Posted:
Aug 21, 2006
Last Update Posted:
Aug 21, 2006
Last Verified:
May 1, 2005
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2006